Dr. Tayar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- SUNY Downstate Health Sciences UniversityFellowship, Rheumatology, 2002 - 2004
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 1998 - 2002
- St Joseph's University Medical SchoolClass of 1997
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- TX State Medical License 2008 - 2026
- WA State Medical License 2023 - 2026
- GA State Medical License 2023 - 2025
- LA State Medical License 2004 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 26 citationsSelective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events.Faisal Fa'ak, Maryam Buni, Adewunmi Falohun, Huifang Lu, Juhee Song
Journal for Immunotherapy of Cancer. 2023-06-01 - 17 citationsNew understanding and approaches to treatment in rheumatoid arthritisJean Tayar, Maria E. Suarez-Almazor
British Medical Bulletin. 2010-06-01 - 8 citationsUtilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer.Xerxes Pundole, Natalia V. Zamora, Harish Siddhanamatha, Heather Lin, Jean Tayar
Clinical Rheumatology. 2020-03-01
Authored Content
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
Press Mentions
- Metastatic Melanoma Survivor Finds Hope in Clinical TrialsAugust 20th, 2019
- After My Acute Myeloid Leukemia Treatment, Check-Ups Feel like a ReunionJuly 30th, 2019
- LupusMarch 18th, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: